ICON PE Ratio 2010-2023 | ICLR
Current and historical p/e ratio for ICON (ICLR) from 2010 to 2023. The price to earnings ratio is calculated by taking the latest closing price and dividing it by the most recent earnings per share (EPS) number. The PE ratio is a simple way to assess whether a stock is over or under valued and is the most widely used valuation measure. ICON PE ratio as of April 19, 2024 is 23.75.
Please refer to the Stock Price Adjustment Guide for more information on our historical prices.
| ICON PE Ratio Historical Data | |||
|---|---|---|---|
| Date | Stock Price | TTM Net EPS | PE Ratio |
| 2024-04-19 | 288.23 | 39.06 | |
| 2023-12-31 | 283.07 | $7.38 | 38.36 |
| 2023-09-30 | 246.25 | $6.20 | 39.72 |
| 2023-06-30 | 250.20 | $6.17 | 40.55 |
| 2023-03-31 | 213.59 | $6.18 | 34.56 |
| 2022-12-31 | 194.25 | $6.13 | 31.69 |
| 2022-09-30 | 183.78 | $5.63 | 32.64 |
| 2022-06-30 | 216.70 | $2.52 | 85.99 |
| 2022-03-31 | 243.22 | $2.49 | 97.68 |
| 2021-12-31 | 309.70 | $2.95 | 104.98 |
| 2021-09-30 | 262.02 | $3.93 | 66.67 |
| 2021-06-30 | 206.71 | $6.82 | 30.31 |
| 2021-03-31 | 196.37 | $6.34 | 30.97 |
| 2020-12-31 | 194.98 | $6.14 | 31.76 |
| 2020-09-30 | 191.09 | $6.00 | 31.85 |
| 2020-06-30 | 168.46 | $6.00 | 28.08 |
| 2020-03-31 | 136.00 | $6.79 | 20.03 |
| 2019-12-31 | 172.23 | $6.80 | 25.33 |
| 2019-09-30 | 147.34 | $6.66 | 22.12 |
| 2019-06-30 | 153.97 | $6.48 | 23.76 |
| 2019-03-31 | 136.58 | $6.10 | 22.39 |
| 2018-12-31 | 129.21 | $5.89 | 21.94 |
| 2018-09-30 | 153.75 | $5.57 | 27.60 |
| 2018-06-30 | 132.53 | $5.38 | 24.63 |
| 2018-03-31 | 118.14 | $5.26 | 22.46 |
| 2017-12-31 | 112.15 | $5.13 | 21.86 |
| 2017-09-30 | 113.88 | $5.16 | 22.07 |
| 2017-06-30 | 97.79 | $4.94 | 19.80 |
| 2017-03-31 | 79.72 | $4.89 | 16.30 |
| 2016-12-31 | 75.20 | $4.72 | 15.93 |
| 2016-09-30 | 77.37 | $4.50 | 17.19 |
| 2016-06-30 | 70.01 | $4.39 | 15.95 |
| 2016-03-31 | 75.10 | $4.20 | 17.88 |
| 2015-12-31 | 77.70 | $3.98 | 19.52 |
| 2015-09-30 | 70.97 | $3.74 | 18.98 |
| 2015-06-30 | 67.30 | $3.51 | 19.17 |
| 2015-03-31 | 70.53 | $3.20 | 22.04 |
| 2014-12-31 | 50.99 | $2.87 | 17.77 |
| 2014-09-30 | 57.23 | $2.53 | 22.62 |
| 2014-06-30 | 47.11 | $2.19 | 21.51 |
| 2014-03-31 | 47.55 | $1.91 | 24.90 |
| 2013-12-31 | 40.42 | $1.65 | 24.49 |
| 2013-09-30 | 40.93 | $1.46 | 28.03 |
| 2013-06-30 | 35.43 | $1.30 | 27.25 |
| 2013-03-31 | 32.29 | $1.15 | 28.08 |
| 2012-12-31 | 27.76 | $0.99 | 28.04 |
| 2012-09-30 | 24.37 | $0.72 | 33.85 |
| 2012-06-30 | 22.53 | $0.39 | 57.77 |
| 2012-03-31 | 21.22 | $0.39 | 54.41 |
| 2011-12-31 | 17.11 | $0.38 | 45.03 |
| 2011-09-30 | 16.08 | $0.67 | 24.00 |
| 2011-06-30 | 23.56 | $1.04 | 22.65 |
| 2011-03-31 | 21.59 | $1.21 | 17.84 |
| 2010-12-31 | 21.90 | $1.44 | 15.21 |
| 2010-09-30 | 21.62 | $1.59 | 13.60 |
| 2010-06-30 | 28.89 | $1.66 | 17.40 |
| 2010-03-31 | 26.41 | $1.59 | 16.61 |
| 2009-12-31 | 21.73 | $1.57 | 13.84 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Services | $24.074B | $8.120B |
| ICON plc is a global full service clinical research organisation. The company provides contract clinical research services to the pharmaceutical industry worldwide. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Elevance Health (ELV) | United States | $122.212B | 15.32 |
| Cencora (COR) | United States | $47.337B | 18.89 |
| DiDi Global (DIDIY) | China | $22.638B | 0.00 |
| Avantor (AVTR) | United States | $16.482B | 22.71 |
| CochLear (CHEOY) | $13.356B | 0.00 | |
| Viatris (VTRS) | United States | $13.340B | 3.81 |
| Revvity (RVTY) | United States | $12.276B | 21.37 |
| EUROFINS SCIENT (ERFSF) | Luxembourg | $12.132B | 0.00 |
| Charles River Laboratories (CRL) | United States | $11.721B | 21.37 |
| Medpace Holdings (MEDP) | United States | $11.598B | 42.15 |
| Solventum (SOLV) | United States | $11.046B | 0.00 |
| Natera (NTRA) | United States | $10.540B | 0.00 |
| Amplifon S.p.A (AMFPF) | Italy | $7.290B | 37.01 |
| HealthEquity (HQY) | United States | $6.851B | 51.19 |
| Bausch + Lomb (BLCO) | Canada | $5.032B | 19.35 |
| Doximity (DOCS) | United States | $4.630B | 34.47 |
| Organon (OGN) | United States | $4.566B | 4.42 |
| Sotera Health (SHC) | United States | $3.085B | 15.14 |
| Progyny (PGNY) | United States | $3.064B | 51.42 |
| Surgery Partners (SGRY) | United States | $2.965B | 27.55 |
| Life Times (LTH) | United States | $2.756B | 30.46 |
| GoodRx Holdings (GDRX) | United States | $2.658B | 134.60 |
| Premier (PINC) | United States | $2.491B | 9.12 |
| Teladoc Health (TDOC) | United States | $2.232B | 0.00 |
| Agilon Health (AGL) | United States | $2.203B | 0.00 |
| AMN Healthcare Services Inc (AMN) | United States | $2.133B | 6.90 |
| BrightSpring Health Services (BTSG) | United States | $1.762B | 0.00 |
| Establishment Labs Holdings (ESTA) | $1.444B | 0.00 | |
| Agiliti (AGTI) | United States | $1.366B | 22.31 |
| NovoCure (NVCR) | Jersey | $1.297B | 0.00 |
| Alignment Healthcare (ALHC) | United States | $0.964B | 0.00 |
| Pediatrix Medical (MD) | United States | $0.740B | 7.66 |
| Embecta (EMBC) | United States | $0.596B | 3.94 |
| Auna S.A (AUNA) | Luxembourg | $0.549B | 0.00 |
| InnovAge Holding (INNV) | United States | $0.544B | 0.00 |
| COMPASS Pathways (CMPS) | United Kingdom | $0.522B | 0.00 |
| Enhabit (EHAB) | United States | $0.507B | 45.96 |
| MultiPlan (MPLN) | United States | $0.475B | 0.00 |
| Beauty Health (SKIN) | United States | $0.423B | 0.00 |
| CareDx (CDNA) | United States | $0.418B | 0.00 |
| LifeMD (LFMD) | United States | $0.412B | 0.00 |
| Sonida Senior Living (SNDA) | United States | $0.391B | 0.00 |
| DocGo (DCGO) | United States | $0.356B | 57.00 |
| Sera Prognostics (SERA) | United States | $0.317B | 0.00 |
| ModivCare (MODV) | United States | $0.286B | 3.79 |
| Ascend Wellness Holdings (AAWH) | United States | $0.269B | 0.00 |
| GeneDx Holdings (WGS) | United States | $0.249B | 0.00 |
| Sharecare (SHCR) | United States | $0.227B | 0.00 |
| Biodesix (BDSX) | United States | $0.121B | 0.00 |
| So-Young (SY) | China | $0.119B | 40.00 |
| Oncology Institute (TOI) | United States | $0.091B | 0.00 |
| Pono Capital Two (PTWO) | United States | $0.061B | 0.00 |
| IceCure Medical (ICCM) | Israel | $0.056B | 0.00 |
| NeueHealth (NEUE) | United States | $0.052B | 0.00 |
| Co-Diagnostics (CODX) | United States | $0.036B | 0.00 |
| Nutex Health (NUTX) | United States | $0.033B | 0.00 |
| SeaStar Medical Holding (ICU) | United States | $0.030B | 0.00 |
| NeuroOne Medical Technologies (NMTC) | United States | $0.030B | 0.00 |
| Singular Genomics Systems (OMIC) | United States | $0.029B | 0.00 |
| OncoCyte (OCX) | United States | $0.021B | 0.00 |
| DermTech (DMTK) | United States | $0.020B | 0.00 |
| BIMI Holdings (BIMI) | United States | $0.016B | 0.00 |
| BioNexus Gene Lab (BGLC) | $0.015B | 0.00 | |
| Aesthetic Medical Hldngs Group (AIH) | China | $0.013B | 0.00 |
| TRxADE HEALTH (MEDS) | United States | $0.008B | 0.00 |
| Intelligent Bio Solutions (INBS) | United States | $0.008B | 0.00 |
| OpGen (OPGN) | United States | $0.008B | 0.00 |
| XWELL (XWEL) | United States | $0.006B | 0.00 |
| Assure Holdings (IONM) | United States | $0.004B | 0.00 |
| ISpecimen (ISPC) | United States | $0.004B | 0.00 |
| NewGenIvf Group (NIVF) | Singapore | $0.003B | 0.00 |
| Aclarion (ACON) | United States | $0.002B | 0.00 |